Wincit M 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedating antihistamine, selectively antagonizes peripheral H1 receptors, thereby reducing symptoms like sneezing, nasal congestion, itching, and rhinorrhea. Montelukast, a leukotriene receptor antagonist, inhibits the action of cysteinyl leukotrienes, which are inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema. The synergistic effect of these agents provides comprehensive relief from allergic symptoms by targeting multiple pathways in the inflammatory cascade. Wincit M is typically prescribed for adults and adolescents aged 15 years and above, with the dosage and duration tailored according to clinical response. It is generally well tolerated; however, some patients may experience adverse effects such as headache, fatigue, dry mouth, or gastrointestinal discomfort. Caution is advised in patients with hepatic impairment or a history of neuropsychiatric events. Wincit M should be used under medical supervision, and patients are advised to report any unusual symptoms promptly. This combination therapy offers an effective option for improving quality of life in patients suffering from persistent allergic conditions.